Where is Toku Eyes located?

Toku Eyes is headquartered in Auckland, New Zealand.

Who is the current CEO of Toku Eyes?

Ehsan Vaghefi of Toku Eyes. They have also founded 1 company.

Which legal entities is Toku Eyes associated with?

Toku Eyes is associated with Toku Eyes Limited.

How many employees does Toku Eyes have?

As of Jun 30, 2026, the latest employee count at Toku Eyes is 21.

Is Toku Eyes a funded company?

Toku Eyes is a funded company, having raised a total of $10.5M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round.

When was the latest funding round of Toku Eyes?

Toku Eyes' latest funding was a $***** Series A round on Apr 17, 2023, with participation from 2 investors.

Where does Toku Eyes rank among its competitors?

Toku Eyes ranks 1st amongst 45 active competitors, of which 8 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Big Vision, which secured $4.15M in May, 2024.

Who are the top competitors of Toku Eyes?

Toku Eyes' top competitors include Cassini, Diagnostear and Konan Medical. Among them, Big Vision secured the most recent funding round in May, 2024.

Toku Eyes - 2026 Company Profile, Team, Funding & Competitors

Toku Eyes is an acquired company based in Auckland (New Zealand), founded in 2018 by David Squirrell and Ehsan Vaghefi. It operates as a Developer of AI-powered retinal image analysis for early disease detection. This company offers tools that analyze retinal images to identify indicators of various health conditions, including cardiovascular risk and chronic kidney disease. The technology utilizes artificial intelligence to provide non-invasive, real-time assessments, potentially enabling earlier diagnosis and intervention. The company's products are subject to varying regulatory approvals depending on the region.. Toku Eyes has raised $10.5M in funding from investors like National Vision, Topconhealthcare and Icehouse Ventures. The company has 45 active competitors, including 8 funded and 5 that have exited. Its top competitors include companies like Cassini, Diagnostear and Konan Medical.

Company Details

{}

Key Metrics

Founded Year

2018

Location

Auckland, New Zealand

Stage

Acquired

Total Funding

$10.5M in 3 rounds

Latest Funding Round

Series A, Apr 17, 2023, $*****

Investors

National Vision & 17 more

Ranked

1^st among 45 active competitors

Employee Count

21 as on Jun 30, 2026

Similar Companies

Cassini & 60 more

Exit Details

Acquired by Topconhealthcare (Oct 17, 2025)

View Toku Eyes' full profile

Toku Eyes is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Toku Eyes Limited CIN: 6656034 , New Zealand, Active	Jan 18, 2018	-	-

Toku Eyes got acquired by Topconhealthcare on Oct 17, 2025.

Click here to take a look at Toku Eyes's acquisition in detail

Toku Eyes has raised a total funding of $10.5M over 3 rounds. Its latest funding round was a Series A round on Apr 17, 2023 for $*****. 2 investors participated in its latest round. Toku Eyes has 11 institutional investors and 7 angel investors.

Here is the list of recent funding rounds of Toku Eyes:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 17, 2023	7573548	Series A	9172121	1379600	5491504	6217981
Jun 29, 2021	4108355	Seed	5605671	6300552	Icehouse Ventures	Artemis & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Toku Eyes's funding rounds and investors

The founders of Toku Eyes are David Squirrell and Ehsan Vaghefi. Ehsan Vaghefi is the CEO of Toku Eyes.

Here are the details of Toku Eyes' key team members:

David Squirrell: Co-Founder of Toku Eyes.
Ehsan Vaghefi: Co-Founder & CEO of Toku Eyes.
Contact Info: 1 email address

View details of Toku Eyes's Founder profiles and Board Members

Toku Eyes' employee count trend

Toku Eyes has 21 employees as of Jun 26. Here is Toku Eyes's employee count trend over the years:

Uncover Toku Eyes' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Toku Eyes include Cassini, Diagnostear and Konan Medical. Here is the list of Top 10 competitors of Toku Eyes, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Toku Eyes 2018, Auckland (New Zealand), Acquired	Developer of AI-powered retinal image analysis for early disease detection. This company offers tools that analyze retinal images to identify indicators of various health conditions, including cardiovascular risk and chronic kidney disease. The technology utilizes artificial intelligence to provide non-invasive, real-time assessments, potentially enabling earlier diagnosis and intervention. The company's products are subject to varying regulatory approvals depending on the region.	$10.5M	National Vision, Masfen Group & 16 others	56/100
2nd	Cassini 2006, The Hague (Netherlands), Series A	Provider of corneal diagnostic solutions	$547K	IPF Partners, Innovation Industries	53/100
3rd	Diagnostear 2013, Tel Aviv (Israel), Public	Point-of-care diagnostic assay for Dry Eye Syndrome	$2.85M	Elcam Medical	45/100
4th	Konan Medical 1947, Orange (United States), Unfunded	Diagnostic devices for Ophthalmology	-	-	42/100
5th	TearLab 2003, San Diego (United States), Acquired	Developer of diagnostic tests for detecting hyperosmolarity	-	CRG, Greybrook	40/100
6th	Octlight 2014, Lyngby (Denmark), Seed	Provider of non-invasive medical imaging light sources for eye diagnosis	$1.44M	Syddansk Innovation, Ministry of Education and Research ... & 4 others	37/100
7th	Pr3vent 2017, San Francisco (United States), Series A	Provider of AI-based platform for ophthalmic conditions in newborns	$2.5M	Trousdale Ventures, Skyview Ventures & 1 others	37/100
8th	Shanggong Medical Letter 2014, Beijing (China), Series A	Provider of fundus screening and chronic disease management	$7.32M	DM Capital, Korea Investment Partners & 3 others	37/100
9th	BioLight 2005, Tel Aviv (Israel), Public	Diagnostics and therapeutics for ophthalmology	-	-	36/100
10th	Big Vision 2015, Suzhou (China), Series A	Provider of ophthalmology diagnosis and analysis systems	$8.52M	SND Ventures Group, Kunshan High-tech Venture Capital ... & 1 others	36/100